Milestone Scientific/$MLSS
1D1W1MYTD1Y5YMAX
Capital at risk
About Milestone Scientific
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
- Ticker
- $MLSS
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 15
- Headquarters
- Roseland, United States
- Website
- www.milestonescientific.com
MLSS Metrics
BasicAdvanced
$38M
-
-$0.05
1.05
-
Price and volume
Market cap
$38M
Beta
1.05
52-week high
$0.60
52-week low
$0.22
Average daily volume
137K
Financial strength
Current ratio
1.846
Quick ratio
0.709
Long term debt to equity
0.138
Total debt to equity
0.177
Interest coverage (TTM)
-102.78%
Profitability
EBITDA (TTM)
-4.025
Gross margin (TTM)
70.23%
Net profit margin (TTM)
-43.98%
Operating margin (TTM)
-43.56%
Revenue per employee (TTM)
$630,000
Management effectiveness
Return on assets (TTM)
-31.28%
Return on equity (TTM)
-121.67%
Valuation
Price to revenue (TTM)
3.819
Price to book
10.85
Price to tangible book (TTM)
10.99
Price to free cash flow (TTM)
-54.706
Free cash flow yield (TTM)
-1.83%
Free cash flow per share (TTM)
-0.008
Growth
Revenue change (TTM)
3.72%
Earnings per share change (TTM)
-43.58%
3-year revenue growth (CAGR)
-1.85%
10-year revenue growth (CAGR)
-1.35%
3-year earnings per share growth (CAGR)
-22.71%
10-year earnings per share growth (CAGR)
-14.97%
What the Analysts think about MLSS
Analyst ratings (Buy, Hold, Sell) for Milestone Scientific stock.
Analyst projections of the future price of Milestone Scientific stock.
MLSS Financial Performance
Revenues and expenses
MLSS Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.